✦ LIBER ✦

The effect of centralization of primary surgery on survival in ovarian cancer patients

✍ Scribed by Solveig Tingulstad; Finn Egil Skjeldestad; Bjørn Hagen

Book ID: 117191896
Publisher: Lippincott Williams and Wilkins
Year: 2003
Tongue: English
Weight: 117 KB
Volume: 102
Category: Article
ISSN: 0029-7844
DOI: 10.1016/s0029-7844(03)00579-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of cytoreductive surgery on survi

Effect of cytoreductive surgery on survival of patients with recurrent epithelial ovarian cancer

✍ Rong Yu Zang; Zhi Yi Zhang; Zi Ting Li; Jie Chen; Mei Qin Tang; Qin Liu; Shu Mo 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB 👁 2 views

The effect of obesity on survival in pat

The effect of obesity on survival in patients with ovarian cancer

✍ Kellie S. Matthews; J. Michael Straughn Jr.; Meredith K. Kemper; Kelly E. Hoskin 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 336 KB

Primary chemotherapy-associated effect o

Primary chemotherapy-associated effect of second-line chemotherapy on survival of patients with advanced ovarian cancer

✍ Seiji Isonishi; Masanori Hirama; Motoaki Saitou; Makoto Yasuda; Tadao Tanaka 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 286 KB

Role of primary surgery in advanced ovar

Role of primary surgery in advanced ovarian cancer

✍ Karsten Münstedt; Folker E Franke 📂 Article 📅 2004 🏛 BioMed Central 🌐 English ⚖ 593 KB

Ovarian cancer in the elderly: Impact of

Ovarian cancer in the elderly: Impact of surgery on morbidity and survival

✍ E. Chéreau; M. Ballester; F. Selle; R. Rouzier; E. Daraï 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 178 KB

Effect of obesity on survival in epithel

Effect of obesity on survival in epithelial ovarian cancer

✍ Maurie Markman 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 35 KB 👁 1 views

## Effect of Obesity on Survival in Epithelial Ovarian Cancer I n a recent report in Cancer, Pavelka et al described a provocative association between obesity and inferior survival in patients with stage III/IV ovarian cancer. 1 Although the authors acknowledged the limitations of their retrospect